An observational, prospective cohort study to evaluate the safety and effectiveness of Remsima® in the treatment of inflammatory bowel disease among Saudi Arabia patients diagnosed with Crohn’s disease, ulcerative colitis, or fistulizing CD
2020-07-04
عنوان الدراسة
An observational, prospective cohort study to evaluate the safety and effectiveness of Remsima® in the treatment of inflammatory bowel disease among Saudi Arabia patients diagnosed with Crohn’s disease, ulcerative colitis, or fistulizing CD
داعم الدراسة
Hikma Pharmaceuticals
دواء الدراسة
Remsima
رقم بروتوكول الدراسة
RMS-KSA-20
حالة الدراسة
Ongoing
موقع الدراسة
King Abdulaziz University Hospital (Jeddah)
مرحلة الدراسة
4
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。